HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heart Valve Diseases (Valvular Heart Disease)

Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
Also Known As:
Valvular Heart Disease; Disease, Heart Valvular; Heart Disease, Valvular; Heart Valve Disease; Heart Valvular Diseases; Valve Disease, Heart; Valvular Disease, Heart; Heart Valvular Disease; Valvular Heart Diseases
Networked: 1865 relevant articles (56 outcomes, 179 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Atrial Fibrillation
2. Heart Failure
3. Endocarditis
4. Cardiomyopathies (Cardiomyopathy)
5. Dilated Cardiomyopathy (Cardiomyopathy, Congestive)

Experts

1. Tribouilloy, Christophe: 12 articles (10/2016 - 08/2010)
2. Cosyns, Bernard: 12 articles (02/2015 - 04/2004)
3. Fuster, Valentin: 11 articles (01/2021 - 03/2010)
4. Levy, Robert J: 10 articles (01/2022 - 12/2002)
5. Lancellotti, Patrizio: 10 articles (01/2021 - 01/2009)
6. Droogmans, Steven: 10 articles (02/2015 - 09/2007)
7. Van Camp, Guy: 9 articles (10/2018 - 04/2004)
8. Jobic, Yannick: 9 articles (10/2016 - 04/2010)
9. Lip, Gregory Y H: 8 articles (10/2019 - 05/2010)
10. Maréchaux, Sylvestre: 8 articles (10/2016 - 04/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Heart Valve Diseases:
1. AnticoagulantsIBA
2. DiureticsIBA
01/01/2019 - "Valvular heart disease and NYHA class III were negatively associated with the use of ACEIs while previous hospitalization for heart failure, old age, diuretic use, and diuretic dose were predictors of suboptimal dosing of ACEIs. "
01/01/2021 - "Precipitating factors were anemia (OR = 2.42; 95%CI: 1.16-5.02; p = 0.021), progressive valvular heart disease (OR = 3.52; 95%CI: 1.35-7.85; p = 0.009), acute kidney injury (OR = 6.98; 95%CI: 2.32-20.96; p < 0.001), time to diuretic administration >60 minutes after ED arrival (OR = 3.89; 95%CI: 2.16-7.00; p < 0.001), and no discharge advice for follow-up (OR = 2.30; 95%CI: 1.10-4.77; p = 0.028). "
08/01/2020 - "Univariate predictors of poorer TTR included Indigenous ethnicity, younger age, diuretic use, and comorbidities, such as valvular heart disease, heart failure and chronic obstructive pulmonary disease (p<0.05 for all). "
04/01/1987 - "The associations between 6 echocardiographic measurements and ventricular arrhythmias on 1-hour ambulatory electrocardiograms were evaluated in 3,348 subjects of the Framingham Heart Study who were free of symptomatic coronary artery disease, congestive heart failure and valvular heart disease and were not receiving diuretic drugs or other blood pressure or cardiac medications. "
09/01/2019 - "The cream formula with the efficacy of restoring deficiency can not only alleviate symptoms and improve the quality of life,but also improve the structure and function of the heart,reduce the dosage of diuretics and the number of hospitalizations,and achieve the purpose of secondary prevention in the treatment of severe heart failure,dilated cardiomyopathy,ischemic cardiomyopathy and valvular heart disease. "
3. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
4. Carnitine (L-Carnitine)FDA LinkGeneric
5. Warfarin (Coumadin)FDA LinkGeneric
6. Pergolide (Permax)FDA Link
7. apixabanIBA
8. FenfluramineIBA
9. CabergolineFDA LinkGeneric
10. Natriuretic PeptidesIBA

Therapies and Procedures

1. Therapeutics
2. Maze Procedure
3. Radiofrequency Ablation
4. Surgical Instruments (Clip)
5. Prostheses and Implants (Prosthesis)